BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9058515)

  • 1. CA19-9: a possible serum marker for embryonal carcinoma.
    Tsuruta T; Ogawa A; Ishii K; Ikado S
    Urol Int; 1997; 58(1):20-4. PubMed ID: 9058515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.
    Kamoshida S; Satoh Y; Yasuda M; Kajiwara H; Tsukinoki K; Osamura RY
    Oncol Rep; 2002; 9(4):845-51. PubMed ID: 12066220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
    Wegman SJ; Parwani AV; Zynger DL
    Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding protein LIN28 is a marker for testicular germ cell tumors.
    Cao D; Allan RW; Cheng L; Peng Y; Guo CC; Dahiya N; Akhi S; Li J
    Hum Pathol; 2011 May; 42(5):710-8. PubMed ID: 21288558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
    Lau SK; Weiss LM; Chu PG
    Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum CA19-9 levels in testicular germ cell tumor patients].
    Suzuki K; Tokue A
    Hinyokika Kiyo; 2001 Jul; 47(7):467-72. PubMed ID: 11523129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratubular Teratoma: A Rare Form of Testicular Germ Cell Neoplasia.
    Genco IS; Ratzon F; Glickman L; Santagada E; Unger P
    Int J Surg Pathol; 2019 Aug; 27(5):556-560. PubMed ID: 30907201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase II alpha expression in testicular germ cell tumors.
    Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
    Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
    Osman H; Cheng L; Ulbright TM; Idrees MT
    Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
    Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
    Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of neutrophil to lymphocyte ratio with testicular cancer.
    Ilktac A; Dogan B; Ersoz C; Akcay M; Akbulut H
    Int Braz J Urol; 2020; 46(1):101-107. PubMed ID: 31851466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
    Badia RR; Abe D; Wong D; Singla N; Savelyeva A; Chertack N; Woldu SL; Lotan Y; Mauck R; Ouyang D; Meng X; Lewis CM; Majmudar K; Jia L; Kapur P; Xu L; Frazier AL; Margulis V; Strand DW; Coleman N; Murray MJ; Amatruda JF; Lafin JT; Bagrodia A
    J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
    Nonaka D
    Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonal carcinoma producing DU-PAN-2 with burned-out phenomenon in the testis.
    Fujita K; Itoh Y; Wada R; Nagao K; Fujime M
    Int J Urol; 2006 Apr; 13(4):473-5. PubMed ID: 16734880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological classification and biological behavior of germ cell tumors of the testis. Studies based on surgery and autopsy data 1958-1979].
    Kruse C; Wittstock G
    Arch Geschwulstforsch; 1984; 54(1):53-9. PubMed ID: 6703862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
    Uysal Z; Bakkaloğlu M
    Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.